Pit-bull reviewing, the pursuit of perfection and the victims of success by Robertson, Miranda
Earlier this year, Hidde Ploegh published in Nature a cri 
de  coeur  on  the  tyranny  (sic)  of  reviewers  [1];  more 
recently,  Gregory  Petsko,  not  (according  to  his  own 
account [2]) generally an advocate of the addition of yet 
more journals to the existing myriad, extended a welcome 
[3]  to  the  news  of  the  open  access  publication  to  be 
launched next year by the Howard Hughes Institute, the 
Wellcome  Trust  and  the  Max  Planck  Institute.  Last 
month, HHMI, Wellcome and MPI released, along with 
the name of the new journal – eLife – a short manifesto 
in  which  they  explain  what  the  journal  is  intended  to 
achieve, and why, and how it will be done.
Meanwhile, our most viewed article for the past year 
has been Virginia Walbot’s ‘Are we training pit bulls to 
review our manuscripts?’ [4].
Ploegh,  Petsko  and  Walbot  have,  with  considerable 
eloquence and varying degrees of passion, described the 
problem that eLife is intended to address: the success of a 
postdoctoral Fellow in finding a good academic position 
is perceived to depend, and to a large extent probably 
does depend, on his or her having published a paper in 
one of the three highest-profile general biology journals; 
but  getting  a  paper  into  one  of  those  journals  can  be 
extraordinarily difficult because – it is widely felt (and see 
[1-3]) – referees seem to see it as their responsibility to 
insist  on  time-consuming  additions  and  revisions,  and 
editors are unable or unwilling to judge for themselves 
the justice of the referees’ advice.
Virginia  Walbot  [4]  has  suggested  how  the  reviewer 
problem could be avoided by training graduate students 
to adopt a more constructive and judicious approach to 
refereeing. We have for the past three years or so been 
operating a policy of ‘re-review opt-out’[5]: authors who 
have been asked to make substantive revisions to their 
papers are also asked whether they wish the referees to 
see the revised version; if not, the decision is made by the 
editors (more below on how this policy has worked in 
practice).
The  solution  proposed  by  eLife  is  to  ensure  quality, 
speed and justice by deploying a high-powered editorial 
board who will oversee the reviewing process and 150 
highly  selected  biomedical  experts  who  will  do  the 
reviewing;  to  avoid  iterations  by  making  a  yes-or-no 
decision  on  first  review;  and  to  promote  fairness  and 
transparency  by  publishing  the  (anonymous)  referees’ 
reports. This is not very different in principle from the 
way  that  at  least  some  other  general  biology  journals 
operate; and the stated aims of eLife – to deliver quick, 
fair  and  intelligent  (‘high-quality’)  decisions  –  are,  I 
imagine, shared by all journals aspiring to the selective 
publication of papers with claims to general interest.
Why are these aims not (apparently) being met by the 
journals in which postdocs feel they must publish?
The belief that has driven the development of eLife is 
that  it  should  be  professional  scientists  who  make 
decisions  on  publication,  and  the  perceived  problems 
arise when they are made by professional editors. There 
are obvious reasons (rehearsed, for example, by Petsko 
[3]) to expect that professional scientists will make better 
decisions than professional editors on scientific papers. 
But this raises the question of why and how the three 
journals that are currently perceived to have a strangle-
hold on the careers of young biologists, all of them run by 
professional editors, came to be in that position.
Clearly I am an interested party in this argument, so 
before presenting a few points bearing on the issues, I 
should like to state that I think a perfectly good case can 
be made both for professional editors and for professional 
scientists  as  the  ultimate  adjudicators  on  scientific 
submissions,  and  it  is  a  good  idea  to  have  journals 
operating  on  both  systems.  I  should  also  add  the 
disclaimer that I am sure there is nothing in what I have 
to  say  that  the  funders  and  extremely  distinguished 
professionals at present engaged in launching eLife are 
unaware of.
Principle and practice
It  is  clear  that  scientists  will  be  better  equipped  to 
evaluate  scientific  papers,  and  indeed  one  anothers’ 
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with a scientific background. But to meet the aspirations 
of eLife (or any other would-be general-interest selective 
biology journal) demands a breadth and depth of know-
ledge, with the sagacity to apply it appropriately, that are 
in limited supply, as is the time of professional scientists, 
especially knowledgeable and sagacious ones.
The main arguments in favor of professional editors are 
that  they  can  make  a  full-time  commitment  to  their 
editorial role, and they are less likely to be influenced by 
personal scientific prejudices and history (their own and 
those of close colleagues) than are field scientists. Their 
effectiveness however depends entirely on their willing-
ness  to  draw  on  the  scientific  community  for  expert 
advice, not only as referees, but also for perspective on 
difficult decisions and adjudication in cases of conflict or 
dispute. Woe betide the professional editor who thinks 
she or he can judge the issues without reference to the 
real experts.
Benjamin Lewin has long since retired from Cell, so it 
is not, I hope, invidious to cite him as an example of a 
professional editor (he was also of course the publisher) 
with the vision and understanding to launch what was 
and is now by any criterion an egregiously successful and 
high-quality  journal.  (Lewin  –  and  Cell  –  have  some 
distinguished detractors, as well as many admirers; but 
you  don’t  get  distinguished  detractors  without  having 
achieved  something  important.  Perhaps  here  I  should 
follow Petsko’s example [3] of full disclosure, and volun  teer 
that  Lewin  and  I  were  for  a  while  colleagues  on  the 
editorial staff of Nature, where we fought like cat and dog.)
Of  course,  some  professional  editors  are  better  than 
others. So are some scientists, in an editorial capacity. 
The main difference is that research scientists constitute 
a community within which the quality of an individual 
can reasonably reliably be judged by consensus criteria, 
whereas no such community or consensus criteria exist 
for editors.
However,  it  seems  to  me  that  the  problem  that  is 
actually at the root of the frustrations with publishing in 
the  biomedical  sciences  is  the  scarcity  of  expertise, 
breadth and sagacity relative to the number of papers on 
which their authors have a right to expect they will be 
exercised. This simply makes it very difficult to achieve 
consistently fair and intelligent decisions, and it is even 
more difficult to couple this with speed.
Worse,  once  a  journal  has  become  one  of  the  high-
profile,  high-impact-factor  few  in  which  all  ambitious 
postdocs hope to publish, there is a danger not only that 
the number of submissions will exceed any reasonable 
capacity  for  consistently  making  good  quick  decisions, 
but that the incentive to editors to ensure such decisions 
concomitantly  decreases,  since  the  reputation  of  the 
journal is by that time sufficient to ensure its continued 
success  in  the  absence  of  anything  but  egregious  and 
consistent lapses. (And possibly even then.)
In  this  way,  aspiring  young  authors  can  become  the 
victims of the journals’ success.
I don’t think there is an infallible formula for getting 
the  publishing  process  right.  But  there  are  certainly 
useful guidelines. Apropos of which, I promised to return 
to our own experiment in the pursuit of perfection in the 
editorial process.
Re-review opt-out and the pursuit of perfection
When  we  initiated  the  policy  of  allowing  authors  to 
choose whether their revised manuscripts were subjected 
to a second scrutiny by their referees, our main fear was 
not  the  risk  of  publishing  invalid  science,  but  that  of 
losing good referees. This fear proved unfounded (although 
there is no way of knowing whether this is simply because 
most referees never read far enough down the invitation 
letter to reach the paragraph explaining that the authors 
may opt out of re-review).
How  have  authors  responded?  Roughly  half  of  all 
authors choose not to go back to referees after revising 
their  papers.  As  editors,  if  we  are  in  doubt  about  the 
validity of the revised paper, we generally reject it. In that 
case, authors sometimes appeal and ask us to consult the 
referees again, and on one or two occasions, the referees 
have proved more tolerant than we were (usually this is 
to do with the level of validation that should reasonably 
be required).
Often, authors would prefer on balance to have their 
revised manuscripts ratified by the reviewers, but want to 
avoid  delay:  in  that  case,  we  generally  offer  to  consult 
referees again with the proviso that if they don’t respond 
within a week we will make a decision without them.
In the interests of avoiding delay to the publication of 
papers at least some of whose results are valid and worthy 
of publication, even if they do not quite meet the strongest 
claims  of  the  authors,  we  also  often  offer  authors  the 
alternatives  of  strengthening  their  paper  for  possible 
publi  cation in BMC Biology, or resubmitting to one of 
our  subject-specific  sister  journals  of  the  BMC  series 
where  it  may  be  acceptable  with  only  minor  or  no 
revisions  to  meet  the  existing  referees’  criticisms.  We 
consider this an extremely important service to authors 
submitting to a journal that maintains a threshold based 
on a judgement of the importance or general interest of 
the papers submitted to it, and not just their scientific 
soundness.
Do  we,  in  consequence  of  our  policy,  make  more 
mistakes than other journals? It’s much too soon to say.
Footnotes
Finally, I should like to return to more general issues, and 
to endorse strongly one remark of Hidde Ploegh [1], and 
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and Editorial Board member Gregory Petsko [3].
It is very important, as Ploegh recommends [1], that 
editors be willing to take the time to establish, by consult-
ing appropriate experts, how important and how reason-
able the demands of referees for additional experiments 
may be; and that they make their position transparent to 
the  authors  in  delivering  their  decision  and  don’t 
equivocate. (This is not trivial to achieve – vide supra.)
Petsko, I think, is a little unfair in castigating the high-
profile journals for publishing a relatively high proportion 
of papers that turn out to be seriously wrong. Journals 
with a claim to general interest should be prepared to 
take  risks  on  non-mainstream  papers,  and  they  will 
inevitably sometimes prove wrong. (That said, it should 
be possible to avoid publishing papers that were clearly 
wrong, or highly likely to prove wrong, at the time of 
publication, and it seems this is not always avoided.)
I also have some comments on the issue of length and 
the absence of page limits; but enough is enough, and 
they will have to wait for another editorial.
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